SGX Financial statements

iX Biopharma Ltd. 1H26 Financial Results: Revenue Decline, Improved Net Loss & No Dividend Declared for 2025 Interim Period

Minichart
February 9, 2026

iX Biopharma Ltd. Interim Results Analysis – 1H FY2026 iX ...

Continue Reading 0